Target intelligence / Profile preview

Varicella-zoster Virus Antigen (VZV Antigen)

Target
VZV Antigen
Molecular classification
Viral protein, Glycoprotein, Envelope glycoprotein
01

Overview

Varicella-zoster virus antigens—primarily envelope glycoproteins such as gE—are essential structural proteins involved in viral infectivity, pathogenesis, immune evasion/modulation, diagnosis via serology, and serve as key targets/components for effective vaccination strategies against chickenpox and shingles.

Other names
VZV GlycoproteinGlycoprotein E (gE)Glycoprotein B (gB)Glycoprotein H (gH)Glycoprotein L (gL)
02

Mechanism of action

Antibody-mediated neutralization of viral entry and spread

03

Biological functions

Viral entry/fusionCell-to-cell spreadImmune recognitionViral replication
04

Disease associations

Chickenpox (Varicella)Shingles (Herpes Zoster)Infection
05

Safety considerations

Potential for vaccine-related adverse reactions (e.g., injection site pain, fever)Rare cases of herpes zoster following vaccination
06

Interacting drugs

Vaccines (e.g., Shingrix®)
07

Biomarkers

Anti-VZV IgG antibodiesgE-specific antibodies

Beyond the preview

Go deeper on Varicella-zoster Virus Antigen (VZV Antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Varicella-zoster Virus Antigen (VZV Antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call